Trials / Completed
CompletedNCT00186381
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 16 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.
Detailed description
To use high dose chemotherapy with autologous stem cell rescue to try to increase the chance of long term control and cure of the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | high dose chemotherapy then autologous hematopoietic cell transplant |
Timeline
- Start date
- 1995-11-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2005-09-16
- Last updated
- 2010-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00186381. Inclusion in this directory is not an endorsement.